CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses
CRISPRed B Cells Produce Antibodies Against Hard-to-Treat Viruses

In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).

In line with previous research, a new study in mice demonstrates that B cells can be engineered to ward off infections, this time against respiratory syncytial virus (RSV).

immunology
Innate Immune Cells May Actually Remember Their Targets
Innate Immune Cells May Actually Remember Their Targets
Emma Yasinski | May 10, 2019
Human natural killer cells, previously considered not to participate in adaptive immunity, remember viral antigens after initial exposures, according to a new study.
Genetically Modified Viral Cocktail Treats Deadly Bacteria in Teen
Genetically Modified Viral Cocktail Treats Deadly Bacteria in Teen
Ashley Yeager | May 8, 2019
Tweaking the genomes of two phages and combining them with a third phage helped to clear a persistent Mycobacterium infection in the patient.
Image of the Day: Amoeba Nibbles
Image of the Day: Amoeba Nibbles
Chia-Yi Hou | May 2, 2019
A pathogenic amoeba species ingests parts of human cells and steals human cell membrane proteins to display on its own surface.
Peanut Allergy Immunotherapy Increases Anaphylaxis Risk: Study
Peanut Allergy Immunotherapy Increases Anaphylaxis Risk: Study
Kerry Grens | Apr 26, 2019
Although the oral treatment seems to work, an analysis of the results from 12 clinical trials finds kids who got an immunotherapy have a greater rate of serious reactions.
A Revised CAR T for Lymphoma Has Fewer Side Effects
A Revised CAR T for Lymphoma Has Fewer Side Effects
Kerry Grens | Apr 23, 2019
An early-stage clinical study finds that none of the 25 patients treated developed neurotoxicity or cytokine release syndrome, common hazards of the cancer immunotherapy.
Image of the Day: Microbes At War
Image of the Day: Microbes At War
Chia-Yi Hou | Apr 23, 2019
Scientists identify microbes in mice that help defend against Salmonella.
Gene Therapy Effective for Severe Combined Immunodeficiency
Gene Therapy Effective for Severe Combined Immunodeficiency
Shawna Williams | Apr 17, 2019
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
Image of the Day: Macrophages in Action
Image of the Day: Macrophages in Action
Chia-Yi Hou | Apr 5, 2019
Researchers watch cellular interactions in high definition as the immune cells absorb E. coli bacteria.
Image of the Day: Tuft Cells
Image of the Day: Tuft Cells
Chia-Yi Hou | Apr 3, 2019
After a severe case of flu, mice have chemosensory cells in their lungs, a place where they don’t normally occur.